Transcriptional Characterization of Glioma Neural Stem Cells Diva ...

[456] T. Shima, N. Okumura, T. Takao, Y. Satomi, T. Yagi, M. Okada, and K. Nagai.
Interaction of the sh2 domain of fyn with a cytoskeletal protein, β-adducin. Journal
of Biological Chemistry, 276(45):42233–42240, 2001.
[457] M. Shipitsin and K. Polyak. The cancer stem cell hypothesis: in search of definitions,
markers, and relevance. Laboratory Investigation, 88(5):459–463, 2008.
[458] S. Singh, I. Clarke, M. Terasaki, V. Bonn, C. Hawkins, J. Squire, and P. Dirks. Identification
of a cancer stem cell in human brain tumors. Cancer Research, 63(18):5821,
2003.
[459] S. Singh, C. Hawkins, I. Clarke, and J. Squire. Identification of human brain tumour
initiating cells. Nature, 2004.
[460] P. Singha, I. Yeh, M. Venkatachalam, P. Saikumar, et al. Transforming growth factor
beta-inducible gene tmepai converts tgf-beta from a tumor suppressor to a tumor
promoter in breast cancer. Cancer research, 70(15):6377–6383, 2010.
[461] D. Smadja, C. d’Audigier, L. Weiswald, C. Badoual, V. Dangles-Marie, L. Mauge,
S. Evrard, I. Laurendeau, F. Lallemand, S. Germain, et al. The wnt antagonist
dickkopf-1 increases endothelial progenitor cell angiogenic potential. Arteriosclerosis,
thrombosis, and vascular biology, 30(12):2544–2552, 2010.
[462] K. Smith, M. Luong, and G. Stein. Pluripotency: toward a gold standard for human
es and ips cells. Journal of cellular physiology, 220(1):21–29, 2009.
[463] B. J. M. D. C. B. G. R. Smith SJ, Long A. Pediatric high-grade glioma: identification
of poly(adp-ribose) polymerase as a potential therapeutic target. Neuro-oncology,
13:1171–1177, 2011.
[464] G. Smyth. Linear models and empirical bayes methods for assessing differential expression
in microarray experiments. Statistical applications in genetics and molecular
biology, 3(1):3, 2004.
[465] G. Smyth. Limma: linear models for microarray data. Bioinformatics and computational
biology solutions using R and Bioconductor, pages 397–420, 2005.
[466] G. Smyth and T. Speed. Normalization of cdna microarray data. Methods, 31(4):265–
273, 2003.
[467] D. A. Solomon, J.-S. Kim, W. Jean, and T. Waldman. Conspirators in a capital
crime: co-deletion of p18INK4c and p16INK4a/p14ARF/p15INK4b in glioblastoma
multiforme. Cancer Research, 68(21):8657–8660, Nov. 2008.
[468] J. Soos, J. Krieger, O. Stüve, C. King, J. Patarroyo, K. Aldape, K. Wosik, A. Slavin,
P. Nelson, J. Antel, et al. Malignant glioma cells use mhc class ii transactivator
(ciita) promoters iii and iv to direct ifn-γ-inducible ciita expression and can function
as nonprofessional antigen presenting cells in endocytic processing and cd4+ t-cell
activation. Glia, 36(3):391–405, 2001.
[469] A. Stark, J. Brennecke, N. Bushati, R. B. Russell, and S. M. Cohen. Animal MicroR-
NAs confer robustness to gene expression and have a significant impact on 3’UTR
evolution. Cell, 123(6):1133–46, 2005.
[470] A. Stark, J. Brennecke, R. B. Russell, and S. M. Cohen. Identification of Drosophila
MicroRNA targets. PLoS Biol, 1(3):E60, 2003.
[471] C. StrÃÂijbing, G. Ahnert-Hilger, J. Shan, B. Wiedenmann, J. Hescheler, and A. M.
Wobus. Differentiation of pluripotent embryonic stem cells into the neuronal lineage
in vitro gives rise to mature inhibitory and excitatory neurons. Mechanisms of Development,
53(2):275–287, 1995.
[472] R. Stupp, W. P. Mason, M. J. van den Bent, M. Weller, B. Fisher, M. J. B. Taphoorn,
K. Belanger, A. A. Brandes, C. Marosi, U. Bogdahn, J. Curschmann, R. C. Janzer,
S. K. Ludwin, T. Gorlia, A. Allgeier, D. Lacombe, J. G. Cairncross, E. Eisenhauer,
R. O. Mirimanoff, E. O. for Research, T. of Cancer Brain Tumor, R. Groups, and
N. C. I. of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant
temozolomide for glioblastoma. The New England journal of medicine, 352(10):987–
996, Mar. 2005.
[473] X. Su, C. Kong, and P. Stahl. Gapex-5 mediates ubiquitination, trafficking, and
degradation of epidermal growth factor receptor. Journal of Biological Chemistry,
282(29):21278–21284, 2007.